Somatoforme Störungen und Hypochondrie

• Literatur

• Kroenke K, Mangelsdorff D. Common symptoms in ambulatory care: incidence, evaluation, therapy and outcome.. American Journal of Medicine 1989; 86: 262-266
• Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms.. Social Psychiatry and Psychiatric Epidemiology 2006; 41: 704-712
• Fink P, Hansen MS, Oxhoj ML. The prevalence of somatoform disorders among internal medical inpatients.. Journal of Psychosomatic Research 2004; 56: 413-418
• Schmitz N, Kruse J. The relationship between mental disorders and medical service utilization in a representative community sample.. Social Psychiatry and Psychiatric Epidemiology 2002; 37: 380-386
• Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies.. European Neuropsychopharmacology 2005; 15: 357-376
• Ansseau M, Dierick M, Buntinkx F. et al. High prevalence of mental disorders in primary care.. Journal of Affective Disorders 2004; 78: 49-55
• Creed F, Barsky A. A systematic review of the Epidemiology of somatization disorder and hypochondriasis.. Journal of Psychosomatic Research 2004; 56: 391-408
• Rief W, Hiller W. Somatisierungsstörung und Hypochondrie.. Göttingen: Hogrefe 1998
• Smith RC, Gardiner JC. Administrative database screening to identify somatizing patients.. Medical Care 2006; 44: 799-802
• Rief W, Hiller W. Toward empirically based criteria for somatoform disorders.. Journal of Psychosomatic Research 1999; 46: 507-518
• Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders.. Psychoneuroendocrinology 2005; 30: 996-1002
• Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with Major Depression and Somatization Syndrome.. Psychiatry Research 2001; 105: 165-174
• Rief W, Pilger F, Ihle D, Verkerk R, Scharpe S, Maes M. Psychobiological aspects of somatoform disorders: Contributions of monoaminergic transmitter systems.. Neuropsychobiology 2004; 49: 24-29
• Hakala M, Karlsson H, Kurki T. et al. Volumes of the caudate nuclei in women with somatization disorder and healthy women.. Psychiatry Research: Neuroimaging 2004; 131: 71-78
• Rief W, Broadbent E. Explaining medically unexplained symptoms - models and mechanisms.. Clinical Psychology Review 2007; 27: 821-841
• Barsky AJ. Amplification, somatization, and the somatoform disorders.. Psychosomatics 1992; 33: 28-34
• Rief W, Hiller W, Margraf J. Cognitive aspects in hypochondriasis and the somatization syndrome.. Journal of Abnormal Psychology 1998; 107: 587-595
• Rief W, Nanke A, Emmerich J, Bender A, Zech T. Causal illness attributions in somatoform disorders. Associations with comorbidity and illness behavior.. Journal of Psychosomatic Research 2004; 57: 367-371
• Rief W, Martin A, Rauh E, Zech T, Bender A. Evaluation of general practitioners' training: how to manage patients with unexplained physical symptoms.. Psychosomatics 2006; 47: 304-311
• Kroenke K, Taylor-Vaisey A, Dietrich AJ, Oxman TE. Interventions to improve provider diagnosis and treatment of mental disorders in primary care.. Psychosomatics 2000; 41: 39-52
• Nickel R, Egle UT. Therapie somatoformer Störungen. Manual zur psychodynamisch-interaktionellen Gruppentherapie.. Stuttgart: Schattauer 1999
• Looper KJ, Kirmayer LJ. Behavioral medicine approaches to somatoform disorders.. Journal of Consulting and Clinical Psychology 2002; 70: 810-827
• Rief W, Bleichhardt G, Timmer B. Gruppentherapie für somatoforme Störungen - Behandlungsleitfaden, Akzeptanz und Prozessqualität.. Verhaltenstherapie 2002; 12: 183-191
• Timmer B, Bleichhardt G, Rief W. Effektivität einer stationären Gruppentherapie für somatoforme Störungen. Ergebnisse einer kontrolliert-randomisierten Therapieevaluationsstudie.. Zeitschrift für Klinische Psychologie und Psychotherapie 2003; 33: 24-32
• Nanke A, Rief W. Biofeedback-based interventions in somatoform disorders: a randomized controlled trial.. Acta Neuropsychiatrica 2002; 15: 249-256
• Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: A review of the literature.. Psychosomatic Medicine 2002; 64: 939-950
• Möller HJ, Volz HP, Stoll KD. Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depression.. Acta Neuropsychiatrica 2003; 15: 217-226
• Aragona M, Banchieri L, Perinelli D. et al. Randomized double-blind comparison of serotonergic (Citalopram) versus nonadrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.. European Journal of Pain 2005; 9: 33-38
• Fallon BA. Pharmacotherapy of somatoform disorders.. Journal of Psychosomatic Research 2004; 56: 455-460